Search Results for "Nexia Biotechnologies"
Original Source: Nexia Biotechnologies Inc
Until recently Nexia developed and manufactured complex recombinant proteins in the milk of transgenic goats for medical and industrial applications. The Company's two lead programs were Protexia and BioSteelR.On March 7, 2005, Nexia's, shareholders approved the sale of substantially all its operations and assets related to ProtexiaR to PharmAthene (www.pharmathene.com), a privately held biotechnology company focused on the development of biodefense therapeutics, based in Annapolis, Maryland, USA.
Matching Channels
None
Matching News
Stellar Biotechnologies develops aquaculture system for KLH manufacturing
Stellar Biotechnologies has developed a controlled, commercial-scale aquaculture system for fully sustainable Keyhole Limpet Hemocyanin (KLH) manufacturing.
PORT HUENEME, CA -- (Marketwire) -- 01/17/13 -- Stellar Biotechnologies, Inc. ("Stellar" or the "Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), the world leader in sustainable manufacture of GMP-grad...
PORT HUENEME, CA -- (Marketwire) -- 02/19/13 -- Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) today announced that the Company exceeded its 2012 plan ...
Wilex, Nuclea Biotechnologies form partnership
Pittsfield, Mass-based biomarker pioneer Nuclea Biotechnologies has formed a new long-term partnership with biopharmaceutical company Wilex, which could lead to more effective treatment management for...
BMS pharma deals for oncology biomarkers in collaborative R&D with Adaptive biotechnologies
Bristol-Myers Squibb has entered into a collaborative R&D pharma deals agreement with Adaptive biotechnologies for the discovery of immunological biomarkers in oncology. Under the pharma deals c...
USPTO grants patent to Lifeline Biotechnologies cancer analyzing device
The US Patent and Trademark Office (USPTO) has granted a US Patent NO 8,185,485 B2 to Lifeline Biotechnologies' device used for analyzing thermal data based on breast surface temperature for the detec...
Nuclea Biotechnologies, Inc.: Series B $3.4M
Nuclea Biotechnologies (Pittsfield, MA) a commercial-stage diagnostic company focused on in vitro companion diagnostic assays based on gene and protein expression profiles and biomarkers associated wi...
Fujifilm Diosynth Biotechnologies Expands Mammalian Cell Culture cGMP Capabilities
Fujifilm Diosynth Biotechnologies has announced it is further increasing its contract process development and manufacturing capabilities through the expansion of its services in mammalian cell line de...
Matching PubMed Articles
High Throughput Biotechnology in Traditional Fermented Food Industry.
Traditional fermented food is not only the staple food for most of developing countries but also the key healthy food for developed countries. As the healthy function of these foods are gradually disc...
Development and application of biotechnologies in the metal mining industry.
Metal mining faces a number of significant economic and environmental challenges in the twenty-first century for which established and emerging biotechnologies may, at least in part, provide the answe...
A Comparative Pilot Study of Two Dental Implant Metals in a Pig Model.
PURPOSE:: Successful implant treatment is based on implant stability, absence periimplant inflammation, and a functional interface between implant and bone tissue (direct bone-implant contact). The ai...
Efficacy of bendamustine as salvage treatment in an heavily pre-treated Hodgkin lymphoma.
Global food security and the governance of modern biotechnologies.
